Skip to main content

Management of the Pregnant Woman with Congenital Heart Disease

  • Living reference work entry
  • First Online:
Pediatric Cardiology

Abstract

As the number of adult patients with CHD increase, so do the number of women of childbearing age. While maternal mortality rates are low, women with CHD have higher rates of cardiac complications during pregnancy. Pregnancy among the CHD population should involve: (1) a multidisciplinary approach between cardiology, obstetrics, and anesthesiology, (2) patient education beginning with preconception counseling and contraception management, and (3) close monitoring during gestation and through the postpartum period. Each pregnancy course should be individually tailored, depending on the patient’s structural disease, current state of health and comorbidities. With appropriate risk factor stratification and multidisciplinary management, a successful pregnancy can be an achievable goal for many women with CHD.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Institutional subscriptions

References

  1. Marelli AJ, et al. Lifetime prevalence of congenital heart disease in the general population from 2000 to 2010. Circulation. 2014;130(9):749–56.

    Article  PubMed  Google Scholar 

  2. Gilboa SM, et al. Congenital heart defects in the United States: estimating the magnitude of the affected population in 2010. Circulation. 2016;134(2):101–9.

    Article  PubMed  PubMed Central  Google Scholar 

  3. Lima FV, et al. National trends and in-hospital outcomes in pregnant women with heart disease in the United States. Am J Cardiol. 2017;119(10):1694–700.

    Article  PubMed  Google Scholar 

  4. Opotowsky AR, et al. Maternal cardiovascular events during childbirth among women with congenital heart disease. Heart. 2012;98(2):145–51.

    Article  PubMed  Google Scholar 

  5. Warnes CA. Pregnancy and pulmonary hypertension. Int J Cardiol. 2004;97(Suppl 1):11–3.

    Article  PubMed  Google Scholar 

  6. Canobbio MM, et al. Management of pregnancy in patients with complex congenital heart disease: a scientific statement for healthcare professionals from the American Heart Association. Circulation. 2017;135(8):e50–87.

    Article  PubMed  Google Scholar 

  7. Gouton M, et al. Maternal and fetal outcomes of pregnancy with Fontan circulation: a multicentric observational study. Int J Cardiol. 2015;187:84–9.

    Article  PubMed  Google Scholar 

  8. Pfaller B, et al. Preventing complications in pregnant women with cardiac disease. J Am Coll Cardiol. 2020;75(12):1443–52.

    Article  PubMed  Google Scholar 

  9. Stout KK, et al. 2018 AHA/ACC guideline for the management of adults with congenital heart disease: executive summary: a report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines. Circulation. 2019;139(14):e637–97.

    PubMed  Google Scholar 

  10. Hall ME, George EM, Granger JP. [The heart during pregnancy]. Rev Esp Cardiol. 2011;64(11):1045–50.

    Google Scholar 

  11. Pirani BB, Campbell DM, MacGillivray I. Plasma volume in normal first pregnancy. J Obstet Gynaecol Br Commonw. 1973;80(10):884–7.

    Article  CAS  PubMed  Google Scholar 

  12. Pritchard JA, Rowland RC. Blood volume changes in pregnancy and the puerperium. III. Whole body and large vessel hematocrits in pregnant and nonpregnant women. Am J Obstet Gynecol. 1964;88:391–5.

    Article  CAS  PubMed  Google Scholar 

  13. Taylor DJ, Lind T. Red cell mass during and after normal pregnancy. Br J Obstet Gynaecol. 1979;86(5):364–70.

    Article  CAS  PubMed  Google Scholar 

  14. Robson SC, et al. Serial study of factors influencing changes in cardiac output during human pregnancy. Am J Phys. 1989;256(4 Pt 2):H1060–5.

    CAS  Google Scholar 

  15. Mabie WC, et al. A longitudinal study of cardiac output in normal human pregnancy. Am J Obstet Gynecol. 1994;170(3):849–56.

    Article  CAS  PubMed  Google Scholar 

  16. Duvekot JJ, et al. Early pregnancy changes in hemodynamics and volume homeostasis are consecutive adjustments triggered by a primary fall in systemic vascular tone. Am J Obstet Gynecol. 1993;169(6):1382–92.

    Article  CAS  PubMed  Google Scholar 

  17. Rubler S, Damani PM, Pinto ER. Cardiac size and performance during pregnancy estimated with echocardiography. Am J Cardiol. 1977;40(4):534–40.

    Article  CAS  PubMed  Google Scholar 

  18. Canobbio MM, et al. Pregnancy outcomes after the Fontan repair. J Am Coll Cardiol. 1996;28(3):763–7.

    Article  CAS  PubMed  Google Scholar 

  19. Barbour LA, Pickard J. Controversies in thromboembolic disease during pregnancy: a critical review. Obstet Gynecol. 1995;86(4 Pt 1):621–33.

    Article  CAS  PubMed  Google Scholar 

  20. Robson SC, et al. Cardiac output during labour. Br Med J (Clin Res Ed). 1987;295(6607):1169–72.

    Article  CAS  PubMed  Google Scholar 

  21. Lui GK, et al. Heart rate response during exercise and pregnancy outcome in women with congenital heart disease. Circulation. 2011;123(3):242–8.

    Article  PubMed  Google Scholar 

  22. European Society of Gynecology, et al. ESC guidelines on the management of cardiovascular diseases during pregnancy: the task force on the Management of Cardiovascular Diseases during pregnancy of the European Society of Cardiology (ESC). Eur Heart J. 2011;32(24):3147–97.

    Article  Google Scholar 

  23. Siu SC, et al. Prospective multicenter study of pregnancy outcomes in women with heart disease. Circulation. 2001;104(5):515–21.

    Article  CAS  PubMed  Google Scholar 

  24. Balci A, et al. Prospective validation and assessment of cardiovascular and offspring risk models for pregnant women with congenital heart disease. Heart. 2014;100(17):1373–81.

    Article  PubMed  Google Scholar 

  25. Silversides CK, et al. Pregnancy outcomes in women with heart disease: the CARPREG II study. J Am Coll Cardiol. 2018;71(21):2419–30.

    Article  PubMed  Google Scholar 

  26. Drenthen W, et al. Predictors of pregnancy complications in women with congenital heart disease. Eur Heart J. 2010;31(17):2124–32.

    Article  PubMed  Google Scholar 

  27. Elkayam U, et al. High-risk cardiac disease in pregnancy: part I. J Am Coll Cardiol. 2016;68(4):396–410.

    Article  PubMed  Google Scholar 

  28. Elkayam U, et al. High-risk cardiac disease in pregnancy: part II. J Am Coll Cardiol. 2016;68(5):502–16.

    Article  PubMed  Google Scholar 

  29. Ito S, et al. Genetic considerations for adults with congenital heart disease. Am J Med Genet C Semin Med Genet. 2020;184(1):149–53.

    Article  PubMed  Google Scholar 

  30. Ko JM. Genetic syndromes associated with congenital heart disease. Korean Circ J. 2015;45(5):357–61.

    Article  PubMed  PubMed Central  Google Scholar 

  31. Halpern DG, et al. Use of medication for cardiovascular disease during pregnancy: JACC state-of-the-art review. J Am Coll Cardiol. 2019;73(4):457–76.

    Article  PubMed  Google Scholar 

  32. Nishimura RA, Warnes CA. Anticoagulation during pregnancy in women with prosthetic valves: evidence, guidelines and unanswered questions. Heart. 2015;101(6):430–5.

    Article  CAS  PubMed  Google Scholar 

  33. Writing Committee M, et al. 2020 ACC/AHA guideline for the management of patients with valvular heart disease: executive summary: a report of the American College of Cardiology/American Heart Association Joint Committee on Clinical Practice Guidelines. J Am Coll Cardiol. 2021;77(4):450–500.

    Article  Google Scholar 

  34. Harris RC, et al. Multidisciplinary management of pregnancy in complex congenital heart disease: a model for coordination of care. Congenit Heart Dis. 2014;9(6):E204–11.

    Article  PubMed  Google Scholar 

  35. Mehta LS, et al. Cardiovascular considerations in caring for pregnant patients: a scientific statement from the American Heart Association. Circulation. 2020;141(23):e884–903.

    Article  PubMed  Google Scholar 

  36. Regitz-Zagrosek V, et al. 2018 ESC guidelines for the management of cardiovascular diseases during pregnancy. Eur Heart J. 2018;39(34):3165–241.

    Article  PubMed  Google Scholar 

  37. Warnes CA. Pregnancy and delivery in women with congenital heart disease. Circ J. 2015;79(7):1416–21.

    Article  CAS  PubMed  Google Scholar 

  38. Yap SC, et al. Comparison of pregnancy outcomes in women with repaired versus unrepaired atrial septal defect. BJOG. 2009;116(12):1593–601.

    Article  PubMed  Google Scholar 

  39. Duan R, et al. Pregnancy outcome in women with Eisenmenger’s syndrome: a case series from west China. BMC Pregnancy Childbirth. 2016;16(1):356.

    Article  PubMed  PubMed Central  Google Scholar 

  40. Katsurahgi S, et al. Maternal and fetal outcomes in pregnancy complicated with Eisenmenger syndrome. Taiwanese J Obstet Gynecol. 2019;58(2):183–7.

    Article  PubMed  Google Scholar 

  41. Weiss BM, et al. Outcome of pulmonary vascular disease in pregnancy: a systematic overview from 1978 through 1996. J Am Coll Cardiol. 1998;31(7):1650–7.

    Article  CAS  PubMed  Google Scholar 

  42. Drenthen W, et al. Outcome of pregnancy in women with congenital heart disease: a literature review. J Am Coll Cardiol. 2007;49(24):2303–11.

    Article  PubMed  Google Scholar 

  43. Presbitero P, et al. Pregnancy in cyanotic congenital heart disease. Outcome of mother and fetus. Circulation. 1994;89(6):2673–6.

    Article  CAS  PubMed  Google Scholar 

  44. Avila WS, et al. Maternal and fetal outcome in pregnant women with Eisenmenger’s syndrome. Eur Heart J. 1995;16(4):460–4.

    Article  CAS  PubMed  Google Scholar 

  45. Lopez BM, et al. Eisenmenger syndrome in pregnancy: a management conundrum. J Cardiothorac Vasc Anesth. 2020;34:2813.

    Article  PubMed  Google Scholar 

  46. Wang K, et al. Pregnancy outcomes among 31 patients with tetralogy of Fallot, a retrospective study. BMC Pregnancy Childbirth. 2019;19(1):486.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  47. Veldtman GR, et al. Outcomes of pregnancy in women with tetralogy of Fallot. J Am Coll Cardiol. 2004;44(1):174–80.

    Article  PubMed  Google Scholar 

  48. Balci A, et al. Pregnancy in women with corrected tetralogy of Fallot: occurrence and predictors of adverse events. Am Heart J. 2011;161(2):307–13.

    Article  PubMed  Google Scholar 

  49. Kampman MA, et al. Uteroplacental Doppler flow and pregnancy outcome in women with tetralogy of Fallot. Ultrasound Obstet Gynecol. 2017;49(2):231–9.

    Article  CAS  PubMed  Google Scholar 

  50. Krieger EV, et al. Comparison of risk of hypertensive complications of pregnancy among women with versus without coarctation of the aorta. Am J Cardiol. 2011;107(10):1529–34.

    Article  PubMed  Google Scholar 

  51. Vriend JW, et al. Outcome of pregnancy in patients after repair of aortic coarctation. Eur Heart J. 2005;26(20):2173–8.

    Article  PubMed  Google Scholar 

  52. Jimenez-Juan L, et al. Cardiovascular magnetic resonance imaging predictors of pregnancy outcomes in women with coarctation of the aorta. Eur Heart J Cardiovasc Imaging. 2014;15(3):299–306.

    Article  PubMed  Google Scholar 

  53. Siegmund AS, et al. Pregnancy in women with corrected aortic coarctation: uteroplacental Doppler flow and pregnancy outcome. Int J Cardiol. 2017;249:145–50.

    Article  PubMed  Google Scholar 

  54. Hameed AB, Goodwin TM, Elkayam U. Effect of pulmonary stenosis on pregnancy outcomes–a case-control study. Am Heart J. 2007;154(5):852–4.

    Article  PubMed  Google Scholar 

  55. Drenthen W, et al. Non-cardiac complications during pregnancy in women with isolated congenital pulmonary valvar stenosis. Heart. 2006;92(12):1838–43.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  56. Oylumlu M, et al. Pulmonary balloon valvuloplasty during pregnancy. Case Rep Cardiol. 2012;2012:353168.

    PubMed  PubMed Central  Google Scholar 

  57. Yap SC, et al. Risk of complications during pregnancy in women with congenital aortic stenosis. Int J Cardiol. 2008;126(2):240–6.

    Article  PubMed  Google Scholar 

  58. Lao TT, et al. Balloon valvuloplasty for congenital aortic stenosis in pregnancy. Br J Obstet Gynaecol. 1993;100(12):1141–2.

    Article  CAS  PubMed  Google Scholar 

  59. Tzemos N, et al. Late cardiac outcomes after pregnancy in women with congenital aortic stenosis. Am Heart J. 2009;157(3):474–80.

    Article  PubMed  Google Scholar 

  60. Smok DA. Aortopathy in pregnancy. Semin Perinatol. 2014;38(5):295–303.

    Article  PubMed  Google Scholar 

  61. McKellar SH, et al. Frequency of cardiovascular events in women with a congenitally bicuspid aortic valve in a single community and effect of pregnancy on events. Am J Cardiol. 2011;107(1):96–9.

    Article  PubMed  Google Scholar 

  62. Nanna M, Stergiopoulos K. Pregnancy complicated by valvular heart disease: an update. J Am Heart Assoc. 2014;3(3):e000712.

    Article  PubMed  PubMed Central  Google Scholar 

  63. Curry RA, et al. Marfan syndrome and pregnancy: maternal and neonatal outcomes. BJOG. 2014;121(5):610–7.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  64. Rossiter JP, et al. A prospective longitudinal evaluation of pregnancy in the Marfan syndrome. Am J Obstet Gynecol. 1995;173(5):1599–606.

    Article  CAS  PubMed  Google Scholar 

  65. Meijboom LJ, et al. Pregnancy and aortic root growth in the Marfan syndrome: a prospective study. Eur Heart J. 2005;26(9):914–20.

    Article  PubMed  Google Scholar 

  66. Connolly HM, Warnes CA. Ebstein’s anomaly: outcome of pregnancy. J Am Coll Cardiol. 1994;23(5):1194–8.

    Article  CAS  PubMed  Google Scholar 

  67. Tutarel O, et al. Pregnancy outcomes in women after arterial switch operation for transposition of the great arteries: results from ROPAC (Registry of Pregnancy and Cardiac Disease) of the European Society of Cardiology EURObservational Research Programme. J Am Heart Assoc. 2021;10(1):e018176.

    Article  PubMed  Google Scholar 

  68. Stoll VM, et al. Pregnancy outcomes in women with transposition of the great arteries after an arterial switch operation. JAMA Cardiol. 2018;3(11):1119–22.

    Article  PubMed  Google Scholar 

  69. Cataldo S, et al. Pregnancy following mustard or senning correction of transposition of the great arteries: a retrospective study. BJOG. 2016;123(5):807–13.

    Article  CAS  PubMed  Google Scholar 

  70. D’Souza R, Silversides C. Pregnancy following atrial-switch repair. BJOG. 2016;123(5):814.

    Article  PubMed  Google Scholar 

  71. Fricke TA, et al. Pregnancy outcomes in women after the arterial switch operation. Heart Lung Circ. 2020;29(7):1087–92.

    Article  PubMed  Google Scholar 

  72. Horiuchi C, et al. Pregnancy outcomes and mid-term prognosis in women after arterial switch operation for dextro-transposition of the great arteries – tertiary hospital experiences and review of literature. J Cardiol. 2019;73(3):247–54.

    Article  PubMed  Google Scholar 

  73. Fricke TA, et al. Long-term outcomes of the arterial switch operation. J Thorac Cardiovasc Surg. 2021;163:212.

    Article  PubMed  Google Scholar 

  74. Connolly HM, Grogan M, Warnes CA. Pregnancy among women with congenitally corrected transposition of great arteries. J Am Coll Cardiol. 1999;33(6):1692–5.

    Article  CAS  PubMed  Google Scholar 

  75. Kowalik E, et al. Pregnancy and long-term cardiovascular outcomes in women with congenitally corrected transposition of the great arteries. Int J Gynaecol Obstet. 2014;125(2):154–7.

    Article  PubMed  Google Scholar 

  76. Broda CR, Downing TE, John AS. Diagnosis and management of the adult patient with a failing Fontan circulation. Heart Fail Rev. 2020;25(4):633–46.

    Article  PubMed  Google Scholar 

  77. Drenthen W, et al. Pregnancy and delivery in women after Fontan palliation. Heart. 2006;92(9):1290–4.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  78. Moroney E, et al. Pregnancy in a woman with a Fontan circulation: a review. Obstet Med. 2018;11(1):6–11.

    Article  PubMed  Google Scholar 

  79. Zentner D, et al. Fertility and pregnancy in the Fontan population. Int J Cardiol. 2016;208:97–101.

    Article  PubMed  Google Scholar 

  80. Collins RT II, et al. National in-hospital outcomes of pregnancy in women with single ventricle congenital heart disease. Am J Cardiol. 2017;119(7):1106–10.

    Article  PubMed  PubMed Central  Google Scholar 

  81. Pundi KN, et al. Contraception practices and pregnancy outcome in patients after Fontan operation. Congenit Heart Dis. 2016;11(1):63–70.

    Article  PubMed  Google Scholar 

  82. Canobbio MM, et al. Pregnancy after Fontan operation: early and late outcomes. J Am Coll Cardiol. 2013;61(10 Suppl):E427.

    Article  Google Scholar 

  83. Stout KK, et al. 2018 AHA/ACC guideline for the management of adults with congenital heart disease: executive summary: a report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines. J Am Coll Cardiol. 2019;73(12):1494–563.

    Article  PubMed  Google Scholar 

  84. Enriquez AD, Economy KE, Tedrow UB. Contemporary management of arrhythmias during pregnancy. Circ Arrhythm Electrophysiol. 2014;7(5):961–7.

    Article  PubMed  Google Scholar 

  85. Hartz J, et al. Transvenous nonfluoroscopic pacemaker implantation during pregnancy guided by 3-dimensional electroanatomic mapping. HeartRhythm Case Rep. 2017;3(10):490–2.

    Article  PubMed  PubMed Central  Google Scholar 

  86. Resnik JL, et al. Evaluation of B-type natriuretic peptide (BNP) levels in normal and preeclamptic women. Am J Obstet Gynecol. 2005;193(2):450–4.

    Article  CAS  PubMed  Google Scholar 

  87. Vitale N, et al. Dose-dependent fetal complications of warfarin in pregnant women with mechanical heart valves. J Am Coll Cardiol. 1999;33(6):1637–41.

    Article  CAS  PubMed  Google Scholar 

  88. John AS, et al. Cardiopulmonary bypass during pregnancy. Ann Thorac Surg. 2011;91(4):1191–6.

    Article  PubMed  Google Scholar 

  89. Jha N, et al. Maternal and fetal outcome after cardiac operations during pregnancy: a meta-analysis. Ann Thorac Surg. 2018;106(2):618–26.

    Article  PubMed  Google Scholar 

  90. de Souza JA, et al. Percutaneous balloon mitral valvuloplasty in comparison with open mitral valve commissurotomy for mitral stenosis during pregnancy. J Am Coll Cardiol. 2001;37(3):900–3.

    Article  PubMed  Google Scholar 

  91. Esteves CA, et al. Immediate and long-term follow-up of percutaneous balloon mitral valvuloplasty in pregnant patients with rheumatic mitral stenosis. Am J Cardiol. 2006;98(6):812–6.

    Article  PubMed  Google Scholar 

  92. Sharma JB, et al. Comparative study on maternal and fetal outcome in pregnant women with rheumatic heart disease and severe mitral stenosis undergoing percutaneous balloon mitral valvotomy before or during pregnancy. Indian Heart J. 2018;70(5):685–9.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  93. Vinayakumar D, et al. Maternal and fetal outcomes in pregnant women undergoing balloon mitral valvotomy for rheumatic mitral stenosis. Indian Heart J. 2016;68(6):780–2.

    Article  PubMed  PubMed Central  Google Scholar 

  94. Chengode S, et al. Perioperative management of transcatheter, aortic and mitral, double valve-in-valve implantation during pregnancy through left ventricular apical approach. Ann Card Anaesth. 2018;21(2):185–8.

    PubMed  PubMed Central  Google Scholar 

  95. Hodson R, et al. Transcatheter aortic valve replacement during pregnancy. Circ Cardiovasc Interv. 2016;9(10):e004006.

    Article  PubMed  Google Scholar 

  96. Society for Maternal-Fetal Medicine. Electronic address, p.s.o., et al., Society for Maternal-Fetal Medicine Consult Series #52: Diagnosis and management of fetal growth restriction: (Replaces Clinical Guideline Number 3, April 2012). Am J Obstet Gynecol. 2020;223(4):B2–B17.

    Article  Google Scholar 

  97. Lisa M Hollier, James N Martin Jr., Heidi Connolly, Mark Turrentine, Afshan Hameed, Katherine W Arendt, Octavia Cannon, Lastascia Coleman, Uri Elkayam, Anthony Gregg, Alison Haddock, Stacy M Higgins, Sue Kendig, Robyn Liu, Stephanie R Martin, Dennis McNamara, Wanda Nicholson, Patrick S Ramsey, Laura Riley, Elizabeth Rochin, Stacey E Rosen, Rachel G Sinkey, Graeme Smith, Calondra Tibbs, Eleni Z Tsigas, Rachel Villanueva, Janet Wei, Carolyn Zelop. American college of obstetricians and gynecologists’ presidential task force on pregnancy and heart disease and committee on practice bulletins—obstetrics. Obstet Gynecol. 2019;133(5):1067–72.

    Google Scholar 

  98. Zahn CM, et al. Levels of maternal care verification pilot: translating guidance into practice. Obstet Gynecol. 2018;132(6):1401–6.

    Article  PubMed  PubMed Central  Google Scholar 

  99. Ruys TP, et al. Is a planned caesarean section in women with cardiac disease beneficial? Heart. 2015;101(7):530–6.

    Article  PubMed  Google Scholar 

  100. Ouyang DW, et al. Obstetric outcomes in pregnant women with congenital heart disease. Int J Cardiol. 2010;144(2):195–9.

    Article  PubMed  Google Scholar 

  101. Burgut FT, et al. A study of postpartum depression and maternal risk factors in Qatar. J Psychosom Obstet Gynaecol. 2013;34(2):90–7.

    Article  PubMed  Google Scholar 

  102. Yaqub Y, et al. Postpartum depression and apical ballooning syndrome (takotsubo syndrome). J Obstet Gynaecol Can. 2009;31(8):736–9.

    Article  PubMed  Google Scholar 

  103. Liang JJ, et al. Prevalence and predictors of depression and anxiety among survivors of myocardial infarction due to spontaneous coronary artery dissection. J Cardiopulm Rehabil Prev. 2014;34(2):138–42.

    Article  PubMed  Google Scholar 

  104. Vigl M, et al. Contraception in women with congenital heart disease. Am J Cardiol. 2010;106(9):1317–21.

    Article  PubMed  Google Scholar 

  105. Leonard H, O’Sullivan JJ, Hunter S. Family planning requirements in the adult congenital heart disease clinic. Heart. 1996;76(1):60–2.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  106. Kaemmerer M, et al. Counseling reproductive health issues in women with congenital heart disease. Clin Res Cardiol. 2012;101(11):901–7.

    Article  PubMed  Google Scholar 

  107. Lidegaard O, et al. Hormonal contraception and risk of venous thromboembolism: national follow-up study. BMJ. 2009;339:b2890.

    Article  PubMed  PubMed Central  Google Scholar 

  108. Lidegaard Ø, et al. Thrombotic stroke and myocardial infarction with hormonal contraception. N Engl J Med. 2012;366(24):2257–66.

    Article  CAS  PubMed  Google Scholar 

  109. Oddsson K, et al. Efficacy and safety of a contraceptive vaginal ring (NuvaRing) compared with a combined oral contraceptive: a 1-year randomized trial. Contraception. 2005;71(3):176–82.

    Article  CAS  PubMed  Google Scholar 

  110. Ahrendt H-J, et al. Efficacy, acceptability and tolerability of the combined contraceptive ring, NuvaRing, compared with an oral contraceptive containing 30 μg of ethinyl estradiol and 3 mg of drospirenone. Contraception. 2006;74(6):451–7.

    Article  CAS  PubMed  Google Scholar 

  111. Lopez LM, et al. Skin patch and vaginal ring versus combined oral contraceptives for contraception. Cochrane Database Syst Rev. 2013;2013:CD003552.

    PubMed  PubMed Central  Google Scholar 

  112. Cardiovascular disease and use of oral and injectable progestogen-only contraceptives and combined injectable contraceptives. Contraception. 1998;57(5):315–24.

    Google Scholar 

  113. Vasilakis C, Jick H, Del Mar Melero-Montes M. Risk of idiopathic venous thromboembolism in users of progestagens alone. Lancet. 1999;354(9190):1610–1.

    Article  CAS  PubMed  Google Scholar 

  114. Pijuan-Domènech A, et al. Usefulness of progesterone-only components for contraception in patients with congenital heart disease. Am J Cardiol. 2013;112(4):590–3.

    Article  PubMed  Google Scholar 

  115. Heinemann LA, et al. Oral progestogen-only contraceptives and cardiovascular risk: results from the Transnational Study on Oral Contraceptives and the Health of Young Women. Eur J Contracept Reprod Health Care. 1999;4(2):67–73.

    Article  CAS  PubMed  Google Scholar 

  116. Cromer B, et al. Bone mineral density in adolescent females using injectable or oral contraceptives: a 24-month prospective study. Fertil Steril. 2008;90(6):2060–7.

    Article  PubMed  PubMed Central  Google Scholar 

  117. Clark MK, et al. Bone mineral density changes over two years in first-time users of depot medroxyprogesterone acetate. Fertil Steril. 2004;82(6):1580–6.

    Article  CAS  PubMed  Google Scholar 

  118. Scholes D, et al. Injectable hormone contraception and bone density: results from a prospective study. Epidemiology. 2002;13(5):581–7.

    Article  PubMed  Google Scholar 

  119. Clark M, et al. Bone mineral density loss and recovery during 48 months in first-time users of depot medroxyprogesterone acetate. Fertil Steril. 2006;86(5):1466–74.

    Article  CAS  PubMed  Google Scholar 

  120. Suri V, et al. Safety of intrauterine contraceptive device (copper T 200 B) in women with cardiac disease. Contraception. 2008;78(4):315–8.

    Article  CAS  PubMed  Google Scholar 

  121. Vasilakis C, Jick SS, Jick H. The risk of venous thromboembolism in users of postcoital contraceptive pills. Contraception. 1999;59(2):79–83.

    Article  CAS  PubMed  Google Scholar 

  122. Peterson HB, et al. The risk of pregnancy after tubal sterilization: findings from the U.S. Collaborative Review of Sterilization. Am J Obstet Gynecol. 1996;174(4):1161–70.

    Article  CAS  PubMed  Google Scholar 

  123. Thorne S, MacGregor A, Nelson-Piercy C. Risks of contraception and pregnancy in heart disease. Heart. 2006;92(10):1520–5.

    Article  PubMed  PubMed Central  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Anitha John .

Editor information

Editors and Affiliations

Rights and permissions

Reprints and permissions

Copyright information

© 2023 Springer Nature Switzerland AG

About this entry

Check for updates. Verify currency and authenticity via CrossMark

Cite this entry

Park, A. et al. (2023). Management of the Pregnant Woman with Congenital Heart Disease. In: Abdulla, Ri., et al. Pediatric Cardiology. Springer, Cham. https://doi.org/10.1007/978-3-030-42937-9_98-1

Download citation

  • DOI: https://doi.org/10.1007/978-3-030-42937-9_98-1

  • Received:

  • Accepted:

  • Published:

  • Publisher Name: Springer, Cham

  • Print ISBN: 978-3-030-42937-9

  • Online ISBN: 978-3-030-42937-9

  • eBook Packages: Springer Reference MedicineReference Module Medicine

Publish with us

Policies and ethics